Abeona Therapeutics Inc (NASDAQ:ABEO) gets downgraded to Hold by Maxim Group

ME Staff
-
0

Analyst Ratings For Abeona Therapeutics Inc (NASDAQ:ABEO)

Today, Abeona Therapeutics Inc (NASDAQ:ABEO) stock was downgraded by Maxim Group from Buy to Hold.

There are 3 Hold Ratings, 3 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on Abeona Therapeutics Inc (NASDAQ:ABEO) is Buy with a consensus target price of $19.6667 per share, a potential 709.33% upside.

Some recent analyst ratings include

  • 8/15/2019-Abeona Therapeutics Inc (NASDAQ:ABEO) gets downgraded to Hold by Maxim Group
  • 8/12/2019-Abeona Therapeutics Inc (NASDAQ:ABEO) gets downgraded to Neutral by Cantor Fitzgerald
  • 8/12/2019-Abeona Therapeutics Inc (NASDAQ:ABEO) has coverage initiated with a Buy rating and $15.00 price target
  • 7/26/2019-Abeona Therapeutics Inc (NASDAQ:ABEO) gets downgraded to Neutral by Mizuho with a price target of $4.00
  • 6/27/2018-Abeona Therapeutics Inc (NASDAQ:ABEO) has coverage initiated with a Buy rating and $26.00 price target
  • On 4/11/2019 Stefano Buono, Director, bought 70,000 with an average share price of $7.80 per share and the total transaction amounting to $546,000.00.
  • On 4/8/2019 Stephen B. Howell, Director, bought 4,000 with an average share price of $7.77 per share and the total transaction amounting to $31,080.00.
  • On 9/20/2016 Todd Wider, Director, bought 5,000 with an average share price of $5.48 per share and the total transaction amounting to $27,400.00.
  • On 7/31/2015 Mark J Ahn, Director, bought 18,182 with an average share price of $5.50 per share and the total transaction amounting to $100,001.00.
  • On 1/26/2015 Mark J Ahn, Director, bought 25,000 with an average share price of $4.00 per share and the total transaction amounting to $100,000.00.
  • On 12/24/2014 Steven H Rouhandeh, Director, bought 250,000 with an average share price of $4.00 per share and the total transaction amounting to $1,000,000.00.

Recent Trading Activity for Abeona Therapeutics Inc (NASDAQ:ABEO)
Shares of Abeona Therapeutics Inc closed the previous trading session at 2.43 up +0.040 1.67% with 2.5 shares trading hands.